Description
VOGNOX-GM 2/0.2 is a combination antidiabetic medicine containing Glimepiride 2 mg, Metformin Hydrochloride (SR) 500 mg, and Voglibose 0.2 mg. It is prescribed for the effective management of Type 2 Diabetes Mellitus in adults when diet, exercise, or single-drug therapy alone is not sufficient to maintain healthy blood glucose levels. This triple-combination formulation helps achieve better glycaemic control by targeting different mechanisms responsible for elevated blood sugar.
Glimepiride stimulates the pancreas to release insulin, helping lower blood glucose levels. Metformin Hydrochloride (SR) reduces glucose production in the liver while improving the body’s sensitivity to insulin. Voglibose slows the digestion and absorption of carbohydrates in the intestine, helping reduce the rise in blood sugar after meals. Together, these three active ingredients provide comprehensive blood sugar management and help minimise the risk of diabetes-related complications when used alongside a healthy lifestyle.
Glimepiride, Metformin Hydrochloride & Voglibose Tablets PCD Pharma Franchise, Manufacturer, Supplier – Senen Biotech
Senen Biotech is a trusted pharmaceutical company offering a profitable PCD Pharma Franchise for Glimepiride, Metformin Hydrochloride and Voglibose Tablets across India. As a reliable manufacturer and supplier of high-quality antidiabetic medicines, the company follows stringent quality standards to ensure product safety, efficacy, and consistency. Franchise partners receive monopoly rights, timely product availability, attractive promotional support, quality packaging, and competitive pricing to help expand their business successfully. Senen Biotech is committed to delivering quality healthcare products while building long-term partnerships with distributors and pharma professionals.
Key Benefits of VOGNOX-GM 2/0.2 Tablets
- Helps effectively control blood sugar levels in Type 2 Diabetes.
- Reduces post-meal blood glucose spikes.
- Improves insulin secretion and insulin sensitivity.
- Supports long-term diabetes management when combined with diet and exercise.
- Helps lower the risk of diabetes-related health complications.
- Convenient combination therapy that improves patient compliance.
Potential Side Effects and Precautions
Like all medicines, VOGNOX-GM 2/0.2 Tablets may cause side effects in some individuals. Common side effects include low blood sugar (hypoglycaemia), nausea, abdominal discomfort, diarrhoea, bloating, headache, dizziness, and mild gastrointestinal disturbances. These effects are generally temporary and may vary from person to person.
Patients should take the medicine exactly as prescribed by their healthcare professional. Regular monitoring of blood glucose levels is recommended during treatment. Maintaining a balanced diet, regular physical activity, and routine medical check-ups can help achieve the best treatment outcomes. The medication should not be stopped or the dosage changed without consulting a healthcare provider.
